Niall A Anderson Selected Research

Phosphotransferases (Kinase)

1/2019

Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Niall A Anderson Research Topics

Disease

3	Idiopathic Pulmonary Fibrosis 10/2019 - 07/2016
1	Rheumatoid Arthritis 01/2019
1	Ulcerative Colitis 01/2019
1	Inflammation (Inflammations) 01/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019

Drug/Important Bio-Agent (IBA)

3	IntegrinsIBA 10/2019 - 07/2016
2	AcidsIBA 01/2018 - 07/2016
1	Phosphotransferases (Kinase)IBA 01/2019